- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $70.92M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $86.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $28.91M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $35.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $30.82M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $22.85M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $37.58M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $30.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $105.27M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $126.12M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $125.69M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $146.94M |
| Net Income | Q1 2025 · Dec 31, 2024 | −$98.3M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$21.68M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 27.98M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $185K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$14.87M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $182.95M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $113.54M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.77 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.77 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.55M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $15.74M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$23.29M |